Trial intelligence / Profile preview

Amobarbital Combined with Propofol for Induction in Gynecological Laparoscopic Surgery

NCT06385756Phase 4Not yet recruiting

Sponsor
Tongji Hospital
Start
Jun 2024
Primary completion
Jun 2026
Modality
Small Molecules
01

Overview

Phase 4, randomised, double-blind trial of amobarbital in hemodynamic instability (2 arms), sponsored by Tongji Hospital. Primary endpoint: Mean Arterial Pressure. Planned start Jun 2024; status: not yet recruiting.

02

Drugs

amobarbital
03

Conditions

hemodynamic instability

Beyond the preview

Go deeper on NCT06385756.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06385756.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call